Fluorescent plasma-membrane potential dye assay

• Use a physiologic extracellular assay buffer appropriate for the tested cells, because published assays measured dye responses in intact mammalian cells, bacteria, or plant protoplasts under live-cell conditions rather than fixed-cell conditions.

• Use pharmacologic or ionic modulators only when matched to the biological question, such as BK-channel openers in BK-expressing HEK293 cells, KATP-channel openers/closers in Kir6.2/SUR1 assays, κ-opioid agonists/antagonists in CHO-KOR cells, antimicrobial compounds in bacterial assays, or gramicidin/ionophores for calibration or depolarization controls.

• DiBAC4(3) is a literature-supported anionic voltage-sensitive dye for plasma-membrane potential assays in human cells, HEK293 ion-channel models, bacterial membrane-polarity assays, and plant guard-cell protoplast studies.

• DiBAC4(5) was used with DiIC1(5), annexin V-FITC, and DAPI in a real-time flow-cytometry assay that distinguished plasma-membrane and mitochondrial-potential changes during oncosis.

• FLIPR/FMP membrane-potential dye kits were used for homogeneous fluorescence microplate assays of KATP-channel modulators and κ-opioid-receptor-mediated hyperpolarization.

• Use a fluorescence plate reader or FLIPR-type kinetic reader for microplate assays, a flow cytometer for single-cell fluorescence distributions, or fluorescence/confocal microscopy for single-cell imaging, because these instrument formats were used in published membrane-potential dye assays.

• Prepare live cells or microorganisms under the culture conditions used for the biological model, then place them in an assay-compatible buffer or medium before dye addition.

• For adherent mammalian microplate assays, seed cells in multiwell plates before the assay;
• For flow cytometry, maintain cells in suspension during dye loading and acquisition;
• For bacterial assays, harvest cultures and resuspend them for dye-based kinetic measurement.

• Prepare DiBAC4(3), DiBAC4(5), or FMP dye according to the published assay format being reproduced, and avoid adding unsupported concentrations when adapting across models.

• For absolute or semi-quantitative DiBAC4(3) calibration in human cells, Klapperstück et al. reported that gramicidin-treated fully depolarized cells are preferred over fixation for calibration, and that DiBAC4(3) concentrations below 100 nM gave a near-linear concentration-fluorescence relation in their tested cell systems.

• Establish baseline fluorescence in live cells after dye loading and before stimulation when performing kinetic membrane-potential assays.

• Add the test stimulus or control compound during continuous or repeated fluorescence acquisition, because published FLIPR, flow-cytometry, and bacterial assays measured time-dependent fluorescence changes after agonist, ion-channel modulator, antimicrobial, sodium azide, Triton X-100, or other stimuli.

• For DiBAC4(3), interpret increased fluorescence as depolarization and decreased fluorescence as hyperpolarization in the validated assay context.

• For FMP/FLIPR assays, measure rapid fluorescence changes after compound addition and analyze concentration-response relationships when testing ion-channel or receptor ligands.

• When using flow cytometry for cell-death or viability contexts, combine membrane-potential dyes with viability or cell-death markers only when the combination has been validated for the question, such as annexin V-FITC and DAPI gating in the oncosis assay.

• When testing microbes with membrane-active compounds, pair membrane-potential dye readouts with membrane-integrity dye readouts only when the study question requires distinguishing depolarization from membrane rupture.

• Reported acquisition formats include kinetic microplate fluorescence for KATP-channel, κ-opioid-receptor, and bacterial assays;
• Flow cytometric real-time fluorescence for oncosis;
• And microscopy-based single-cell imaging for membrane-potential responses.

• Exact excitation/emission settings should be taken from the dye and instrument combination used in the cited paper being replicated, because the literature reviewed here supports multiple dye classes and readout platforms rather than one universal optical setting.

• Analyze fluorescence as baseline-normalized change over time, endpoint fluorescence, or concentration-response curves depending on the experimental design.

• In DiBAC4(3)-based assays, higher fluorescence indicates depolarization and lower fluorescence indicates hyperpolarization within validated live-cell conditions.

• In FMP/FLIPR assays, agonist- or modulator-induced fluorescence changes can be used to estimate ligand potency, efficacy, antagonist shifts, or desensitization when concentration-response and repeated-addition designs are included.

• Use positive controls that are mechanistically matched to the model, such as gramicidin for full depolarization calibration, known BK-channel openers for BK-expressing HEK293 cells, KATP-channel openers/closers for Kir6.2/SUR1 cells, κ-opioid agonists and antagonists for CHO-KOR cells, or membrane-active antimicrobials for bacterial depolarization assays.

• Use unstimulated dye-loaded cells as the negative or baseline control, and include viability or membrane-integrity readouts when membrane rupture could confound membrane-potential interpretation.

Problem: DiBAC4(3) fluorescence changes do not match expected membrane-potential changes.

• Possible cause: DiBAC4(3) fluorescence can be influenced by non-voltage factors such as intracellular dye binding and protein content.
• Literature-supported solution: use live-cell calibration with gramicidin-depolarized cells and avoid fixation-based calibration when estimating absolute membrane potential.

Problem: Fast voltage oscillations are poorly resolved.

• Possible cause: DiBAC4(3) has limited temporal resolution and may convert rapid oscillatory hyperpolarization into a slower apparent fluorescence change.
• Literature-supported solution: restrict DiBAC4(3) interpretation to relatively slow membrane-potential changes or use a faster validated membrane-potential assay format when rapid kinetics are required.

Problem: Antimicrobial-treated bacteria show fluorescence changes that could reflect either depolarization or membrane rupture.

• Possible cause: membrane-active compounds can cause ion-permeability changes and membrane permeabilization.
• Literature-supported solution: combine membrane-potential dyes with membrane-integrity dyes such as propidium iodide when the goal is to distinguish depolarization from rupture.

Problem: Cytotoxicity experiments show mixed membrane-potential signals from dying cells.

• Possible cause: apoptotic, oncotic, and dead cells can differ in plasma-membrane potential, mitochondrial potential, annexin V binding, and DAPI permeability.
• Literature-supported solution: combine plasma-membrane potential dye analysis with mitochondrial-potential dye and live/dead gating markers, as reported for real-time oncosis flow cytometry.